Facilities and Programs

First Approved Lupus Drug in 50 Years: What Promise Might it Hold?

The FDA’s approval of Benlysta (belimumab) may only offer modest benefit for some patients, but it’s the first new lupus drug to be endorsed in more than 50 years. We tapped rheumatologist and lupus scientist Jennifer Anolik, M.D., Ph.D., for insight into the drug, its promise, and its importance for patients with the systemic autoimmune disease. Read the Q and A »

Phase II Cardiac Rehab Program Gets Upgrade

Patients who have had heart attacks, surgery or diagnosis of heart disease are benefitting from improvements at the URMC Cardiac Rehabilitation Center. Space dedicated for Phase II rehabilitation was upgraded as patients and caregivers took on the challenge of using the facility while under renovation. Read more about the Rehabilitation Center »

TEMS Offers Minimally Invasive Option for Rectal Cancer

URMC’s division of Colorectal Surgery has expanded its treatments by offering Transanal Endoscopic Microsurgery (TEMS), a minimally invasive technique for the removal of rectal tumors. Read more about these treatments »

IVF Success Rates at Strong Fertility Center Among the Best

With more than half of its embryo transfers resulting in live births, URMC’s Strong Fertility Center surpasses the national average for in vitro fertilization (IVF) in women under 35 years of age. Read more about IVF »

Strong Consult and Transfer Center

Toll-free (800) 499-9298
(585) 275-4999